Recombinant Brassica napus Oleosin Bn-III

Shipped with Ice Packs
In Stock

Description

Introduction to Recombinant Brassica napus Oleosin Bn-III

Recombinant Brassica napus Oleosin Bn-III is a recombinant protein derived from the oleosin family, specifically from the species Brassica napus, commonly known as rapeseed or oilseed rape. Oleosins are structural proteins that coat the surface of oil bodies in plant cells, playing a crucial role in stabilizing these lipid storage organelles and facilitating the accumulation and storage of lipids in seeds and other plant tissues .

Characteristics of Recombinant Brassica napus Oleosin Bn-III

  • Product Type: Recombinant Protein

  • Species: Brassica napus (Rape)

  • Uniprot No.: P29110

  • Tag Info: The tag type is determined during the manufacturing process.

  • Storage Buffer: Tris-based buffer with 50% glycerol.

  • Storage Conditions: Store at -20°C or -80°C. Repeated freezing and thawing is not recommended.

  • Purity: >85% (SDS-PAGE) for some commercial preparations .

Function and Role of Oleosins

Oleosins are essential for maintaining the structural integrity of oil bodies, which are critical for lipid storage and metabolism in plants. These proteins help in preventing the coalescence of oil bodies, ensuring that they remain as small, stable droplets within the cell. This stability is crucial for efficient lipid storage and mobilization during seed germination and plant growth .

Data Table: Characteristics of Recombinant Brassica napus Oleosin Bn-III

CharacteristicDescription
Product TypeRecombinant Protein
SpeciesBrassica napus (Rape)
Uniprot No.P29110
Tag InfoDetermined during production
Storage BufferTris-based buffer with 50% glycerol
Storage Conditions-20°C or -80°C, avoid repeated freezing/thawing
Purity>85% (SDS-PAGE)

References:

  1. cbm15. ELISA Recombinant Brassica napus Oleosin Bn-III.

  2. PMC4652056. Wrinkled1 Accelerates Flowering and Regulates Lipid Homeostasis in Brassica napus.

  3. Cusabio. Recombinant Brassica napus Oleosin Bn-III, partial.

  4. Cusabio. Recombinant Brassica napus Oleosin Bn-III, partial.

  5. PMC6770452. Detection and Identification of Allergens from Canadian Mustard.

  6. UCI Machine Learning Repository. vocab.pubmed.

  7. PMC9674310. Pyruvate transporter BnaBASS2 impacts seed oil accumulation in Brassica napus.

Product Specs

Form
Lyophilized powder Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement. We will accommodate your request whenever possible.
Lead Time
Delivery times vary depending on the purchase method and location. Please contact your local distributor for precise delivery estimates. Note: Our proteins are shipped with standard blue ice packs. Dry ice shipping is available upon request; however, additional charges will apply. Please contact us in advance to arrange this.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and can serve as a guideline.
Shelf Life
Shelf life depends on various factors, including storage conditions, buffer composition, temperature, and the protein's inherent stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process. The specific tag will be determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
Oleosin Bn-III; BnIII
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-195
Protein Length
full length protein
Species
Brassica napus (Rape)
Target Protein Sequence
MTDTARTHHDITSRDQYPRDRDQYSMIGRDRDQYSMMGRDRDQYNMYGRDYSKSRQIAKA VTAVTAGGSLLVLSSLTLVGTVIALTVATPLLVIFSPILVPALITVAMLITGFLSSGGFG IAAITVFSWIYKYATGEHPQGSDKLDSARMKLGSKAQDLKDRAQYYGQQHTGGYGQQHTG GEHDRDRTRGTQHTT
Uniprot No.

Target Background

Function

Oleosin Bn-III may play a structural role in stabilizing lipid bodies within seeds during desiccation, preventing oil coalescence. It likely interacts with both lipid and phospholipid components of lipid bodies. Additionally, it may provide recognition signals for specific lipases, facilitating lipolysis during seedling growth.

Database Links

UniGene: Bna.1245

Protein Families
Oleosin family
Subcellular Location
Lipid droplet. Membrane; Multi-pass membrane protein. Note=Surface of oil bodies. Oleosins exist at a monolayer lipid/water interface.

Q&A

How does Oleosin Bn-III contribute to oil body formation and stability?

Oleosin Bn-III contributes to oil body formation and stability through multiple mechanisms:

  • Steric hindrance: The protein forms a protective layer on the surface of oil bodies, preventing coalescence through steric hindrance.

  • Size regulation: The expression level of oleosins inversely correlates with oil body size, with higher expression leading to smaller, more stable oil bodies .

  • Structural stabilization: The hydrophobic domain anchors firmly in the triacylglycerol matrix while the amphipathic domains interact with the phospholipid monolayer and aqueous cytosol.

  • Signaling functions: Beyond structural roles, evidence suggests oleosins like Bn-III may participate in cellular signaling related to lipid mobilization during germination.

Research has demonstrated that overexpression of oleosin genes in Arabidopsis impacts oil body size. Interestingly, when various oleosin genes from B. napus were overexpressed in Arabidopsis, average oil body size increased slightly in transgenic seeds, except for BnaOLE1 .

What is known about the genetic organization and expression pattern of Oleosin Bn-III?

The oleosin gene family in Brassica napus is complex, with genomic studies identifying 48 oleosin sequences that can be divided into four evolutionary lineages (T, U, SH, SL) . The Oleosin Bn-III gene specifically:

  • Contains a single intron of 437 bp within its coding sequence

  • Is expressed specifically in the embryo during seed development

  • Shows maximal expression between 9 and 11 weeks after flowering, coinciding with the seed desiccation stage

  • Has two transcriptional start sites mapped to -70 and -21 of the ATG

The gene's promoter region contains regulatory elements that drive seed-specific expression, including:

  • A putative ABA-responsive element that mediates responses to abscisic acid, a hormone involved in seed maturation

  • Three repeated motifs that may function as cis-acting elements for embryo-specific gene expression

Studies using promoter-GUS fusion constructs have confirmed that the 872 bp promoter fragment is sufficient to drive seed-specific expression in transgenic plants .

How does the expression of Oleosin Bn-III compare with other oleosins in the B. napus genome?

B. napus contains multiple oleosin genes with distinct expression patterns:

Oleosin TypeExpression PatternEvolutionary LineageKey Features
Oleosin Bn-IIISeed-specific, late embryogenesisSHHighly expressed during seed desiccation
BnaOLE1Seed-specificSLAffects oil body size differently than other oleosins
BnaOLE3Seed-specificTMinimal effect on seed oil content when overexpressed
Other isoformsVarying temporal patternsT, U, SH, SLSome expressed earlier in embryogenesis

Synteny analysis has revealed that most oleosin genes are conserved across Brassicaceae species, and all have experienced purifying selection during evolution, indicating their functional importance . Different isoforms may have specialized roles in oil body formation and maintenance at different stages of seed development and germination.

What expression systems are most effective for producing recombinant Oleosin Bn-III?

Based on current research practices, several expression systems have proven effective for recombinant oleosin production:

  • E. coli expression systems: Most commonly used due to simplicity and high yield. Commercial recombinant Oleosin Bn-III is typically produced in E. coli . This system is particularly suitable for structural studies but may require optimization of codon usage and growth conditions to prevent inclusion body formation.

  • Yeast expression systems: Provide eukaryotic post-translational modifications and are especially useful when studying oleosin interactions with lipids.

  • Plant-based expression systems: Offer the most native-like environment for oleosin folding and assembly into oil bodies.

Each system presents distinct advantages:

Expression SystemAdvantagesChallengesOptimal Applications
E. coliHigh yield, simple protocols, cost-effectivePotential misfolding, lacks PTMsStructural studies, antibody production
YeastEukaryotic PTMs, oil body formationLower yield than bacteriaFunctional studies, protein-lipid interactions
Plant systemsNative folding environmentTime-consuming, lower yieldIn vivo functional studies, oil body assembly

For functional studies requiring properly folded Oleosin Bn-III with authentic interactions with lipids, either yeast or plant-based expression systems may be preferable despite lower yields.

What are effective methods for purifying recombinant Oleosin Bn-III while preserving its functional properties?

Purification of recombinant Oleosin Bn-III presents unique challenges due to its amphipathic nature. Effective methodologies include:

  • Affinity chromatography: Using appropriate tags (His, GST) that can be cleaved post-purification to obtain native protein . The tag type is often determined during the production process to optimize for specific applications .

  • Artificial oil body (AOB) system: Exploiting oleosin's natural affinity for oil-water interfaces by reconstituting it with phospholipids and triacylglycerols, followed by density gradient centrifugation.

  • Detergent solubilization: Using mild detergents to solubilize the hydrophobic domains while maintaining structural integrity.

  • Two-phase extraction: Utilizing aqueous two-phase systems to separate oleosins based on their amphipathic properties.

A recommended purification workflow:

  • Expression with an appropriate affinity tag

  • Initial purification using affinity chromatography under conditions that maintain protein solubility

  • Tag cleavage followed by reverse affinity chromatography

  • Size exclusion chromatography for final polishing

  • Storage in buffer containing 50% glycerol at -20°C to maintain stability

For long-term storage, it is recommended to add 50% glycerol (final concentration) and store in aliquots at -20°C/-80°C. Repeated freezing and thawing should be avoided, and working aliquots can be stored at 4°C for up to one week .

How can recombinant Oleosin Bn-III be used to study oil body biogenesis and stability?

Recombinant Oleosin Bn-III serves as a valuable tool for investigating oil body formation and stability through several experimental approaches:

  • Reconstitution studies: By combining purified recombinant Oleosin Bn-III with phospholipids and triacylglycerols in vitro, researchers can study the minimum requirements for oil body formation and stability.

  • Mutagenesis experiments: Targeted modifications of specific domains (N-terminal, hydrophobic central, or C-terminal) can elucidate their individual contributions to oil body stability.

  • Fluorescent tagging: Fusion of fluorescent proteins to Oleosin Bn-III enables real-time visualization of oil body dynamics in living cells.

  • Interaction studies: Co-expression with other oil body proteins can reveal important protein-protein interactions that regulate oil body size and stability.

  • Comparative analysis: Using recombinant oleosins from different lineages (T, U, SH, SL) to compare their functional properties and evolutionary adaptations.

These approaches have revealed that the hydrophobic domain is essential for oil body targeting, while the amphipathic domains influence oil body size and stability through surface interactions.

What insights have been gained from transgenic studies involving Oleosin Bn-III and related oleosins?

Transgenic studies with oleosins from B. napus have provided several key insights:

  • Impact on oil content: Overexpression of most B. napus oleosin genes in Arabidopsis increased seed oil content slightly, with the exception of BnaOLE3 .

  • Oil body morphology: Transgenic seeds showed altered oil body size, with most oleosin overexpressors having slightly larger oil bodies than wild type, except for BnaOLE1 .

  • Fatty acid composition: Significant changes in fatty acid profiles were observed in transgenic lines:

    • Linoleic acid content increased by up to 13.3%

    • Peanut acid (arachidic acid) content decreased by up to 11%

  • Seed characteristics: Overexpression of oleosin genes led to increased seed size and thousand-seed weight (TSW), potentially contributing to increased total lipid production .

Oleosin GeneEffect on Oil ContentEffect on Oil Body SizeEffect on Fatty Acid ProfileEffect on Seed Size
BnaOLE1Slight increaseNo significant changeIncreased linoleic acidIncreased
BnaOLE2Slight increaseSlight increaseIncreased linoleic acidIncreased
BnaOLE3No significant changeSlight increaseIncreased linoleic acidIncreased
BnaOLE4Slight increaseSlight increaseIncreased linoleic acidIncreased

These findings suggest that oleosins play complex roles beyond their structural functions in oil bodies, potentially influencing broader aspects of seed metabolism and development.

How do post-translational modifications affect Oleosin Bn-III function?

While the search results don't specifically address post-translational modifications (PTMs) of Oleosin Bn-III, research on oleosins suggests several potential modifications that may regulate function:

  • Phosphorylation: May regulate interactions with other proteins or lipids, particularly during seed germination when oil bodies are mobilized.

  • Ubiquitination: Likely targets oleosins for degradation during oil body mobilization.

  • Proteolytic processing: Some oleosins undergo specific cleavage events, as evidenced by the cleaved form of Oleosin-B3 that produces pollen coat protein B3 .

The impact of these modifications on Oleosin Bn-III function remains an active area of research. When working with recombinant Oleosin Bn-III, researchers should consider how the expression system chosen may affect the PTM profile and consequently the functional properties of the protein.

What are emerging biotechnological applications of recombinant Oleosin Bn-III?

Emerging applications for recombinant Oleosin Bn-III include:

  • Artificial oil body technology: Using recombinant oleosins to create stable emulsions for drug delivery, enzyme immobilization, or edible oil stabilization.

  • Protein purification systems: Exploiting the ability of oleosins to partition into oil-water interfaces for developing novel protein purification strategies.

  • Metabolic engineering: Manipulating oleosin expression to alter seed oil content and fatty acid composition, as demonstrated by the increased linoleic acid content in transgenic plants .

  • Biomarkers: Using oleosin-specific antibodies for detecting allergenic proteins in rapeseed products.

  • Structural biology research: Studying oleosins as models for understanding how proteins can stably integrate into lipid environments.

The unique structural properties of Oleosin Bn-III, particularly its ability to stabilize oil-water interfaces, make it a promising candidate for various biotechnological applications beyond its native role in oil seeds.

What are common challenges in working with recombinant Oleosin Bn-III and how can they be addressed?

Researchers often encounter several challenges when working with recombinant Oleosin Bn-III:

  • Protein solubility issues: The highly hydrophobic central domain can cause aggregation during expression and purification.

    • Solution: Use mild detergents or chaotropic agents during extraction, followed by careful refolding protocols. Consider co-expression with chaperones.

  • Structural integrity assessment: Confirming proper folding of the recombinant protein can be difficult.

    • Solution: Employ circular dichroism spectroscopy to assess secondary structure, and functional assays such as oil body reconstitution to verify activity.

  • Storage stability: Recombinant oleosins may lose activity during storage.

    • Solution: Store in 50% glycerol at -20°C or -80°C in small aliquots to avoid repeated freeze-thaw cycles . Working aliquots can be stored at 4°C for up to one week.

  • Purity verification: Standard SDS-PAGE may not accurately reflect oleosin purity due to unusual migration patterns.

    • Solution: Use multiple analytical methods including size exclusion chromatography and mass spectrometry to verify homogeneity.

  • Functional variability: Different batches may show variation in functional properties.

    • Solution: Develop standardized activity assays and include positive controls in each experiment.

How can researchers verify the biological activity of purified recombinant Oleosin Bn-III?

Verifying the biological activity of recombinant Oleosin Bn-III is crucial for ensuring experimental validity. Recommended approaches include:

  • Artificial oil body (AOB) formation assay: Mix purified oleosin with phospholipids and triacylglycerols, then assess oil body size and stability using dynamic light scattering and microscopy.

  • Lipid binding assays: Use fluorescence spectroscopy with labeled lipids to quantify binding affinity and specificity.

  • Circular dichroism (CD) spectroscopy: Compare the secondary structure profile with native protein to verify proper folding.

  • Thermal shift assays: Evaluate protein stability under various conditions to optimize storage and experimental buffers.

  • Functional complementation: Express recombinant Oleosin Bn-III in oleosin-deficient mutants to assess rescue of phenotype.

A comprehensive validation protocol might include:

  • Structural analysis by CD spectroscopy

  • AOB formation assay with size distribution analysis

  • Stress testing of AOB stability under various conditions

  • Comparative analysis with native Oleosin Bn-III isolated from B. napus seeds

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.